Provided by Tiger Trade Technology Pte. Ltd.

Absci Corporation.

2.78
-0.1000-3.47%
Post-market: 2.76-0.0200-0.72%19:49 EDT
Volume:4.21M
Turnover:11.80M
Market Cap:425.40M
PE:-3.30
High:2.96
Open:2.84
Low:2.73
Close:2.88
52wk High:5.23
52wk Low:2.01
Shares:153.02M
Float Shares:132.00M
Volume Ratio:0.76
T/O Rate:3.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8421
EPS(LYR):-0.8421
ROE:-62.50%
ROA:-36.26%
PB:2.25
PE(LYR):-3.30

Loading ...

Absci Doses First Volunteers in Phase 1/2a Trial of AI-Designed Antibody for Hair Loss

Reuters
·
Dec 04, 2025

Absci Announces First Participants Dosed in Phase 1/2a Headline™ Trial of AI-Designed Antibody Abs-201™ for Androgenetic Alopecia

THOMSON REUTERS
·
Dec 04, 2025

Absci Corp: Interim Data Anticipated in Second Half of 2026

THOMSON REUTERS
·
Dec 04, 2025

Absci Corp - Phase 2 Development of Abs-201 in Endometriosis Planned for Q4 2026

THOMSON REUTERS
·
Dec 04, 2025

Miss These Genesis Mission Stocks, and You’ll Regret It for a Decade

InvestorPlace
·
Dec 02, 2025

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), AbSci (ABSI) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Nov 25, 2025

Stock Track | Absci Corporation Plummets 14.85% as Q3 Results Fall Short of Expectations

Stock Track
·
Nov 13, 2025

Absci Is Maintained at Buy by Needham

Dow Jones
·
Nov 13, 2025

Stock Track | Absci Corporation Plummets 11.76% in Pre-market Following Disappointing Q3 Results

Stock Track
·
Nov 13, 2025

Stock Track | Absci Corporation Plunges 9.71% Following Disappointing Q3 Results and Revenue Miss

Stock Track
·
Nov 13, 2025

Stock Track | Absci Shares Plunge 16.77% After-Hours on Q3 Revenue Miss and Wider Losses

Stock Track
·
Nov 13, 2025

Stock Track | Absci Plunges 16.77% After-Hours on Q3 Revenue Miss and Wider-Than-Expected Losses

Stock Track
·
Nov 13, 2025

Absci reports Q3 EPS (20c), consensus (21c)

TIPRANKS
·
Nov 13, 2025

Absci Corporation Showcases AI-Powered Antibody Design and Pipeline Progress in New Presentation

Reuters
·
Nov 13, 2025

Absci reports Q3 revenue of $0.4 million and net loss of $28.7 million

Reuters
·
Nov 13, 2025

BRIEF-Absci Q3 Revenue USD 378 Thousand Vs. IBES Estimate USD 1.52 Million

Reuters
·
Nov 13, 2025

Absci Q3 Operating Expenses USD 30.532 Million

THOMSON REUTERS
·
Nov 13, 2025

AbSci Corp options imply 13.2% move in share price post-earnings

TIPRANKS
·
Nov 13, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

AI Biotech Stocks Shined. Recursion Up 15%; Beam Up 14%; Tempus Up 7%; Novavax Up 6%; Crispr And Ginkgo Up 4%; Hims Up 2%

Tiger Newspress
·
Oct 20, 2025